Artificial Intelligence (AI) in Medical Imaging Market Size & Growth Forecast 2027–2036, By Segments (End-use, Modality, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
AI in Medical Imaging Market size stood at USD 2.72 Billion in 2026 and is predicted to grow at 24.38% CAGR from 2027 to 2036, attaining USD 24.1 Billion by 2036. The industry revenue for 2027 is calculated at USD 3.31 Billion.
Get more details on this report
Request Free Sample ReportArtificial Intelligence (AI) in Medical Imaging Market Intelligence Snapshot
Regional Market Dynamics
- North America held 38.34% in 2026, supported by advanced healthcare technology adoption, digital infrastructure investment, mature imaging ecosystems, and strong AI integration.
- Asia Pacific is projected to grow fastest as hospital modernization, healthcare digitization, advanced diagnostics, AI research, and rising healthcare expenditure accelerate deployment.
Segment Momentum
- Hospitals accounted for 45.05% of the market in 2026 due to high imaging volumes, strong investments in advanced infrastructure, and growing use of AI to improve image interpretation and clinical workflows.
- Ultrasound imaging is projected to grow the fastest as healthcare providers increasingly adopt AI to enhance image quality, automate measurements, and improve diagnostic consistency across diverse clinical settings.
Market Expansion Drivers
- Growing global radiologist shortage accelerating AI-assisted diagnostic imaging adoption
- Advancements in deep learning improving diagnostic accuracy and clinical decision support
- Increasing healthcare R&D investment accelerating AI integration into imaging workflows
Leading Market Participants
- Prominent companies in the AI in medical imaging market include Siemens Healthineers AG (Germany), GE HealthCare Technologies Inc. (United States), Koninklijke Philips N.V. (Netherlands), IBM Corporation (United States), Lunit Inc. (South Korea), NVIDIA Corporation (United States), Microsoft Corporation (United States), Aidoc Medical Ltd. (Israel), Arterys Inc. (United States), Nanox Imaging Ltd. (Israel)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 2.72 Billion
- 2027 Estimated Market Size: USD 3.31 Billion
- Projected Market Size: USD 24.1 Billion by 2036
- Growth Forecast: 24.38% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hospitals (End-use) | X-ray (Modality) | Neurology (Application)
- Emerging Opportunity Segment: Diagnostic Centers (End-use) | Ultrasound Imaging (Modality) | Neurology (Application)
Market Growth Drivers and Industry Trends
Growing global radiologist shortage accelerating AI-assisted diagnostic imaging adoption
Healthcare systems are facing increasing pressure to manage growing imaging volumes with limited specialist availability, a trend that will propel the AI in medical imaging market growth. AI-assisted imaging solutions help prioritize examinations, automate repetitive tasks, and support faster interpretation of diagnostic images, allowing radiologists to focus on complex clinical cases. These capabilities improve workflow efficiency while helping healthcare providers address reporting backlogs and maintain timely diagnostic services across diverse care settings.
Advancements in deep learning improving diagnostic accuracy and clinical decision support
Continuous progress in deep learning algorithms is enhancing the ability of imaging software to identify subtle abnormalities and assist clinicians with evidence-based decision-making, strengthening the AI in medical imaging market. Advanced models trained on extensive medical imaging datasets improve pattern recognition across different imaging modalities, supporting more consistent analysis and reducing variability in image interpretation. The integration of these capabilities into clinical workflows also enables healthcare professionals to make informed decisions with greater confidence during routine and complex diagnostic evaluations.
Increasing healthcare R&D investment accelerating AI integration into imaging workflows
Growing investment in healthcare research and development will drive the AI in medical imaging market growth by accelerating innovation in intelligent diagnostic technologies and workflow automation. Funding directed toward artificial intelligence research supports the development of new imaging applications, validation studies, and interoperability improvements that facilitate adoption within hospitals and diagnostic centers. Collaborative efforts among healthcare institutions, technology developers, and research organizations further encourage the incorporation of AI tools into routine imaging practices while supporting continuous refinement of clinical performance.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Growing global radiologist shortage accelerating AI-assisted diagnostic imaging adoption | 2% | High | North America, Europe | High | Near Term |
| Advancements in deep learning improving diagnostic accuracy and clinical decision support | 1.8% | High | North America, Asia Pacific | High | Near Term |
| Increasing healthcare R&D investment accelerating AI integration into imaging workflows | 1.5% | High | Europe, Asia Pacific | High | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America accounted for 38.34% of the artificial intelligence (AI) in medical imaging market in 2026, reflecting strong adoption of advanced healthcare technologies and substantial investment in digital health infrastructure. The region benefits from a mature medical imaging ecosystem, widespread access to sophisticated diagnostic equipment, and increasing integration of AI tools into radiology and clinical workflows. Healthcare providers are adopting AI-enabled solutions to support image interpretation, improve diagnostic efficiency, prioritize critical cases, and streamline clinical decision-making. Strong research capabilities and growing interest in automation across healthcare are further supporting the deployment of AI-based imaging technologies.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is projected to be the fastest-growing region in the artificial intelligence (AI) in medical imaging market. Expanding healthcare infrastructure, increasing adoption of advanced diagnostic technologies, and growing demand for efficient medical services are creating favorable conditions for AI deployment. Rising healthcare expenditure and the modernization of hospitals are encouraging investments in digital imaging systems and intelligent clinical tools. The region’s large patient population and increasing burden of chronic diseases are also strengthening demand for technologies that can improve diagnostic capacity and support earlier disease detection. Furthermore, growing investments in healthcare digitization and AI research are expected to accelerate the integration of intelligent imaging solutions across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Clinical AI IntegrationThe U.S. market emphasizes integrating AI into radiology workflows, diagnostic decision support, and enterprise imaging platforms. Healthcare providers in the U.S. continue prioritizing solutions that improve clinical efficiency while aligning with evolving regulatory and data governance expectations.
Germany 🇩🇪
Precision Imaging AdoptionGermany focuses on AI applications that complement advanced diagnostic imaging and hospital digitalization initiatives. Healthcare institutions in Germany increasingly evaluate interoperable AI platforms that support consistent image interpretation and workflow optimization across clinical settings.
Japan 🇯🇵
Aging Care DiagnosticsJapan prioritizes AI-enabled imaging technologies that support earlier disease detection and efficient management of age-related health conditions. Healthcare providers in Japan continue expanding imaging automation to address workforce constraints while maintaining diagnostic quality across hospitals.
South Korea 🇰🇷
Digital Imaging InnovationSouth Korea encourages the deployment of AI-enabled medical imaging through digitally advanced healthcare infrastructure and active technology commercialization. Hospitals in South Korea increasingly adopt intelligent imaging solutions that enhance diagnostic productivity and facilitate clinical decision-making.
France 🇫🇷
Hospital Workflow EnhancementFrance emphasizes AI adoption that strengthens diagnostic consistency and improves imaging workflow efficiency within public and private healthcare systems. Medical institutions in France continue assessing validated AI applications that integrate smoothly with existing clinical imaging environments.
Italy 🇮🇹
Diagnostic Modernization FocusItaly is expanding the use of AI in medical imaging to modernize radiology services and improve diagnostic efficiency across healthcare facilities. Healthcare organizations in Italy increasingly invest in interoperable imaging software that supports standardized clinical workflows and resource optimization.
Segment Leadership and Growth Trends
Artificial Intelligence (AI) in Medical Imaging Market Share (%), by End-use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd-use Segment Analysis: Hospitals (Largest Segment) vs Diagnostic Centers (Fastest-Growing Segment)
The hospitals end-use segment dominated the AI in medical imaging market with a market share of 45.05% in 2026 due to the high volume of diagnostic imaging procedures performed across multispecialty healthcare facilities. Hospitals increasingly rely on artificial intelligence to improve image interpretation, streamline clinical workflows, and support faster diagnosis across multiple medical disciplines. Their strong investment capacity, access to advanced imaging infrastructure, and growing emphasis on precision medicine have reinforced the segment’s leadership in 2026.
The diagnostic centers end-use segment is expected to witness the fastest growth as standalone imaging facilities continue to adopt AI-enabled solutions to improve reporting accuracy and enhance operational efficiency. Rising demand for outpatient diagnostic services, shorter turnaround times, and automated image analysis is encouraging diagnostic centers to integrate advanced AI tools into routine clinical practice. The growing need to manage increasing imaging volumes while maintaining consistent diagnostic quality is further supporting rapid expansion within this segment.
Modality Segment Analysis: X-ray (Largest Segment) vs Ultrasound Imaging (Fastest-Growing Segment)
Holding the largest share of the AI in medical imaging market, the X-ray modality segment accounted for 34.02% in 2026 owing to its extensive use as a primary diagnostic imaging technique across hospitals, emergency departments, and outpatient facilities. AI-powered X-ray solutions assist clinicians by improving image interpretation, accelerating detection of abnormalities, and reducing reporting time, making them valuable for managing large patient volumes. The widespread availability and routine use of X-ray systems continue to sustain the segment’s dominant position in 2026.
The ultrasound imaging modality segment is anticipated to grow at the fastest pace as healthcare providers increasingly incorporate artificial intelligence to enhance image quality, automate measurements, and improve diagnostic consistency. The expanding use of ultrasound across point-of-care settings, maternal health, cardiology, and emergency medicine is driving demand for intelligent imaging solutions. Continued advancements in real-time image analysis and portable ultrasound technologies are further supporting rapid adoption within this modality.
Application Segment Analysis: Neurology (Largest & Fastest-Growing Segment)
In the AI in medical imaging market, the neurology application segment held the largest share in 2026 while also emerging as the fastest-growing segment. The increasing prevalence of neurological disorders and the need for rapid, accurate interpretation of complex brain imaging have accelerated the adoption of artificial intelligence in neurological diagnostics. AI technologies assist clinicians in detecting subtle abnormalities, supporting treatment planning, and improving clinical decision-making, while ongoing advancements in imaging algorithms and the growing emphasis on early disease identification continue to strengthen the segment’s leadership and expansion.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End-use | Hospitals, Clinics, Diagnostic Centers, Others | Hospitals | Diagnostic Centers |
| Modality | X-ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound Imaging, Molecular Imaging | X-ray | Ultrasound Imaging |
| Application | Breast Imaging, Lung Imaging, Neurology, Cardiovascular Applications, Liver Imaging, Others | Neurology | Neurology |
Competitive Landscape and Market Positioning
Leading companies in the artificial intelligence (AI) in medical imaging market:
- Siemens Healthineers AG (Germany)
- GE HealthCare Technologies, Inc. (United States)
- Koninklijke Philips N.V. (Netherlands)
- IBM Corporation (United States)
- Lunit, Inc. (South Korea)
- NVIDIA Corporation (United States)
- Microsoft Corporation (United States)
- Aidoc Medical Ltd. (Israel)
- Arterys, Inc. (United States)
- Nanox Imaging Ltd. (Israel)
Artificial intelligence is reshaping competition in medical imaging by shifting differentiation beyond image interpretation toward integrated clinical decision support, workflow optimization, and interoperability with broader healthcare ecosystems. Providers capable of combining advanced algorithms with reliable deployment across diverse imaging environments are gaining a stronger competitive position as healthcare organizations prioritize solutions that improve operational efficiency without disrupting existing clinical practices. Competitive intensity is also increasing as regulatory expectations, data privacy requirements, and demand for explainable outputs encourage sustained investment in validation, software refinement, and long-term platform development. The ability to continuously enhance algorithm performance while supporting multiple imaging modalities and evolving clinical applications is becoming an increasingly important basis for market positioning.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Siemens Healthineers AG (Germany) | |||||||
| GE HealthCare Technologies Inc. (United States) | |||||||
| Koninklijke Philips N.V. (Netherlands) | |||||||
| IBM Corporation (United States) | |||||||
| Lunit Inc. (South Korea) | |||||||
| NVIDIA Corporation (United States) | |||||||
| Microsoft Corporation (United States) | |||||||
| Aidoc Medical Ltd. (Israel) | |||||||
| Arterys Inc. (United States) | |||||||
| Nanox Imaging Ltd. (Israel) |
Industry Development/News
| Company Name | Date | Key Development |
|---|
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Artificial Intelligence (AI) in Medical Imaging Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Workflow Stage | Image Acquisition, Image Reconstruction & Enhancement, Image Interpretation & Analysis, Clinical Decision Support |
| Deployment Model | On-Premises, Cloud-Based, Hybrid |
| AI Technology | Machine Learning, Deep Learning, Computer Vision, Natural Language Processing |
Artificial Intelligence (AI) in Medical Imaging Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| AI Diagnostic Workflow Integration |
|
| Clinical Adoption & Trust Assessment |
|
| Hospital AI Procurement Strategy |
|
Need a different cut of the data?
Request Custom ResearchHow big is the artificial intelligence in medical imaging market?
What is the anticipated CAGR of the artificial intelligence in medical imaging industry?
How is the global radiologist shortage accelerating adoption of AI in medical imaging?
Why is healthcare R&D investment important for the AI in medical imaging market?
Why do hospitals lead the AI in medical imaging market?
Which modality segment is expected to grow the fastest in the AI in medical imaging market?
What supports North America's leadership in AI in medical imaging?
Why is Asia Pacific expected to grow rapidly in AI medical imaging?
Who are the major participants shaping the artificial intelligence in medical imaging landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization